GNC

Double Strength Fish Oil

F
N+ Score58
Omega & Fish OilServing: 1 Softgel(s)Type: Fat/Fatty Acid

GNC Double Strength Fish Oil is a Fat/Fatty Acid supplement focused on Omega & Fish Oil support, containing five ingredients. It holds an N+ Score of 58, which corresponds to an 'F' grade, indicating a below-average quality assessment. This product delivers clinical doses of both Eicosapentaenoic Acid (360mg) and Docosahexaenoic Acid (240mg) per serving, which are key components of fish oil. With a total of five ingredients, the label transparency is good. This supplement is designed for individuals prioritizing specific EPA and DHA intake from fish oil, offering these essential fatty acids at clinically relevant levels.

About This Product

Double Strength Fish Oil by GNC is a omega & fish oil supplement containing 5 active ingredients. It has earned an N+ Score of 58/100 (Grade F).

Notable clinical-dose ingredients include Eicosapentaenoic Acid, Docosahexaenoic Acid.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Calories10.000 {Calories}N/A
Total Fat1.000 gN/A
Eicosapentaenoic Acid360.000 mgAdequate
Docosahexaenoic Acid240.000 mgAdequate
Calories from Fat10.000 {Calories}N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.